Its growing prominence in wealth management is responsible for the rating increase.
The narrow-moat insurance broker is poised to benefit from U.S. employers' gradual migration to private health-care exchanges, but investors should wait for a wider margin of safety.
The private exchange business could widen Aon's and Marsh's moats.
Private exchanges could offer growth catalysts but face challenges, writes Morningstar's Vincent Lui in Part 1 of a series.
We expect fund outflows at PIMCO in the wake of Gross' departure to weigh on Allianz in the next three to five years, but our long-term view for Allianz remains positive
We’re placing PIMCO parent Allianz under review as we assess the impact of the a potential flood of outflows that could follow Bill Gross to Janus.
We expect a progressive change in this insurer's product mix and investment strategies.
The ACA creates opportunities for insurance brokers, with firms like Marsh positioned to benefit the most.
We think Prudential is overvalued and investors could be better off with Aviva.